|
Volumn 62, Issue 11, 2007, Pages 1087-1093
|
The value of hyoscine butylbromide in pelvic MRI
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SCOPOLAMINE BUTYL BROMIDE;
ADULT;
AGED;
ARTICLE;
BLADDER TUMOR;
BLURRED VISION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL TUMOR;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
DIZZINESS;
FEMALE;
HEART PALPITATION;
HEAT SENSATION;
HUMAN;
IMAGE QUALITY;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVARY TUMOR;
PELVIS CANCER;
PERISTALSIS;
PREDICTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PROSTATE TUMOR;
QUESTIONNAIRE;
SCORING SYSTEM;
SIDE EFFECT;
SINGLE BLIND PROCEDURE;
STATISTICAL SIGNIFICANCE;
UTERINE CERVIX CANCER;
XEROSTOMIA;
ADULT;
AGED;
AGED, 80 AND OVER;
BUTYLSCOPOLAMMONIUM BROMIDE;
CONTRAST MEDIA;
FEMALE;
HUMANS;
IMAGE ENHANCEMENT;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
MUSCARINIC ANTAGONISTS;
PELVIC NEOPLASMS;
PERISTALSIS;
PROSPECTIVE STUDIES;
|
EID: 34848847212
PISSN: 00099260
EISSN: None
Source Type: Journal
DOI: 10.1016/j.crad.2007.05.007 Document Type: Article |
Times cited : (65)
|
References (8)
|